RYMAN HEALTHCAR Valuation
RH7 Stock | EUR 2.54 0.01 0.39% |
Based on Macroaxis valuation methodology, the company appears to be fairly valued. RYMAN HEALTHCAR holds a recent Real Value of 2.55 per share. The prevailing price of the company is 2.54. Our model determines the value of RYMAN HEALTHCAR from reviewing the company fundamentals such as current valuation of 3.82 B, and Total Debt of 2.58 B as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that RYMAN HEALTHCAR's price fluctuation is moderately volatile at this time. Calculation of the real value of RYMAN HEALTHCAR is based on 3 months time horizon. Increasing RYMAN HEALTHCAR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the RYMAN stock is determined by what a typical buyer is willing to pay for full or partial control of RYMAN HEALTHCAR. Since RYMAN HEALTHCAR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RYMAN Stock. However, RYMAN HEALTHCAR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.54 | Real 2.55 | Hype 2.54 | Naive 2.77 |
The real value of RYMAN Stock, also known as its intrinsic value, is the underlying worth of RYMAN HEALTHCAR Company, which is reflected in its stock price. It is based on RYMAN HEALTHCAR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of RYMAN HEALTHCAR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of RYMAN HEALTHCAR helps investors to forecast how RYMAN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RYMAN HEALTHCAR more accurately as focusing exclusively on RYMAN HEALTHCAR's fundamentals will not take into account other important factors: RYMAN HEALTHCAR Total Value Analysis
RYMAN HEALTHCAR is at this time forecasted to have takeover price of 3.82 B with market capitalization of 3.82 B, debt of 2.58 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the RYMAN HEALTHCAR fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
3.82 B | 3.82 B | 2.58 B |
RYMAN HEALTHCAR Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of RYMAN indicates not a very effective usage of assets in January.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates RYMAN HEALTHCAR's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in RYMAN HEALTHCAR and how it compares across the competition.
About RYMAN HEALTHCAR Valuation
The stock valuation mechanism determines RYMAN HEALTHCAR's current worth on a weekly basis. Our valuation model uses a comparative analysis of RYMAN HEALTHCAR. We calculate exposure to RYMAN HEALTHCAR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of RYMAN HEALTHCAR's related companies.8 Steps to conduct RYMAN HEALTHCAR's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates RYMAN HEALTHCAR's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct RYMAN HEALTHCAR's valuation analysis, follow these 8 steps:- Gather financial information: Obtain RYMAN HEALTHCAR's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine RYMAN HEALTHCAR's revenue streams: Identify RYMAN HEALTHCAR's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research RYMAN HEALTHCAR's industry and market trends, including the size of the market, growth rate, and competition.
- Establish RYMAN HEALTHCAR's growth potential: Evaluate RYMAN HEALTHCAR's management, business model, and growth potential.
- Determine RYMAN HEALTHCAR's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate RYMAN HEALTHCAR's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for RYMAN Stock analysis
When running RYMAN HEALTHCAR's price analysis, check to measure RYMAN HEALTHCAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RYMAN HEALTHCAR is operating at the current time. Most of RYMAN HEALTHCAR's value examination focuses on studying past and present price action to predict the probability of RYMAN HEALTHCAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RYMAN HEALTHCAR's price. Additionally, you may evaluate how the addition of RYMAN HEALTHCAR to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |